Hemolytic Disease of the Fetus and Newborn
4 clinical trials · Condition
◉ Watch Hemolytic Disease of the Fetus and Newborn
| Record | Firm | Date |
|---|---|---|
| A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry (NCT07194070) | Janssen Research & Development, LLC | 2025-12-17 |
| Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia (NCT06984445) | Institute of Mother and Child, Warsaw, Poland | 2024-07-17 |
| A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) (NCT05912517) | Janssen Research & Development, LLC | 2023-12-20 |
| A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN) (NCT03842189) | Janssen Research & Development, LLC | 2018-04-05 |
Track Hemolytic Disease of the Fetus and Newborn automatically
Every clearance here is in the API, with alerts when new ones post.